Pixar’s ‘Elemental’ Challenge: Originals Aren’t Breaking Big at the Box Office 

This image released by Disney/Pixar Studios shows Ember, voiced by Leah Lewis, in a scene from the animated film "Elemental." (Disney/Pixar via AP)
This image released by Disney/Pixar Studios shows Ember, voiced by Leah Lewis, in a scene from the animated film "Elemental." (Disney/Pixar via AP)
TT

Pixar’s ‘Elemental’ Challenge: Originals Aren’t Breaking Big at the Box Office 

This image released by Disney/Pixar Studios shows Ember, voiced by Leah Lewis, in a scene from the animated film "Elemental." (Disney/Pixar via AP)
This image released by Disney/Pixar Studios shows Ember, voiced by Leah Lewis, in a scene from the animated film "Elemental." (Disney/Pixar via AP)

Pixar, the studio that introduced the world to blockbuster franchises "Toy Story," "Monsters, Inc" and "Cars," has a problem: an original film it spent seven years nurturing bombed at the box office.

The weak opening of "Elemental" this weekend has thrust the Walt Disney-owned animation pioneer into unfamiliar territory: being a laggard among rivals. Universal’s "The Super Mario Bros." movie and Sony’s "Spider-Man: Across the Spider-Verse," both animated films, have racked up big ticket sales this year.

Pixar's love story, about overcoming outward differences, was the second-lowest domestic opening in studio history, taking in roughly $30 million in the US and Canada over the weekend.

The results represent a conundrum for the animation hits factory, say experts and former employees: How will Pixar launch new properties when moviegoing audiences only have time for well-known characters?

"As an industry, we need original IP to work," Tony Chambers, Disney's head of theatrical distribution, said in an interview over the weekend, using shorthand for "intellectual property."

"If we, as a studio, don’t take a swing for it, which is what we did with ‘Elemental,’ you don’t create franchises," Chambers said.

To be sure, the challenge for originals is not Disney’s alone. Universal Studios will confront it later this month with DreamWorks Animation’s coming-of-age fantasy, "Ruby Gillman, Teenage Kraken."

But the trend packs a big wallop at Disney. New cinematic franchises power the entertainment conglomerate's profit machine, feeding the pipeline for consumer products and theme park attractions, which accounted for over 60% of its segment operating profit last year.

Tom Sito, a veteran Hollywood animator whose credits include "The Little Mermaid," "Beauty & The Beast," "Aladdin" and "The Lion King" and who teaches at the University of Southern California, said audience tastes are changing.

"The generation now flexing their economic muscle were raised on games and anime," Sito said. "Their sensibilities and timing are different. Witness the new 'Across The Spider-Verse' movie."

The successes of "Super Mario Bros." and "Spider-Man" also reflect a new post-COVID-19 trend at box offices, Hollywood insiders say. Audiences have been spoiled by three years of direct-to-streaming releases of original animated features on services including Netflix, Disney+ and Apple Inc's Apple TV+ at home. These viewers are now more likely to open their wallets at the cinema only for familiar franchises.

All top 10 movies at the box office in 2022 were sequels — such as "Avatar: The Way of Water" and "Top Gun: Maverick" — or reboots such as "The Batman." This year, "Super Mario Bros." was the first film to break through the $1 billion mark and "Spider-Man: Across the Spider-Verse," a sequel to the 2018 Academy Award-winning movie, has beaten expectations at the box office and is already being talked about as a repeat Oscar contender.

"People went for their comfort zone, which is ongoing sagas," said Jeff Bock, senior box office analyst at Exhibitor Relations Co. "Pixar trying to drop an original piece like 'Elemental' was always going to be a challenge in the middle of this sequel-fest."

Pixar reinvention

Interviews with four current and former Pixar senior managers depict a studio caught in transition and still finding its way under new leadership.

In his book, "Creativity, Inc.," Pixar co-founder Ed Catmull credited Pixar's brain trust with the studio’s early box-office triumphs. He described how the five men who led the creation of its first feature-length animated film, "Toy Story" — John Lasseter, Andrew Stanton, Pete Docter, Lee Unkrich and Joe Ranft — would give candid feedback to elevate films "from suck to not-suck" in an unforgiving process.

Catmull and other members of the original brain trust are gone, though Docter remains, now in the role of chief creative officer. Under him, the studio is placing bets on young directors who bring fresh perspectives — if not extensive resumes — to the screen, such as "Turning Red"’s Chinese-born director, Domee Shi, who was the first woman with a sole director’s credit, or "Soul’s’ Kemp Powers, Pixar’s first Black director.

"What we're seeing is (Pixar) reinventing themselves," said the former Pixar director.

Competitors, meanwhile, have swooped in to raid Pixar’s talent, including Brad Bird, director of the Oscar-winning films "The Incredibles," and "Ratatouille," and Academy Award-winning producer Darla K. Anderson, whose credits include "Coco" and "Toy Story 3."

Former studio executives and insiders also blame former CEO Bob Chapek with training new audiences to expect big-budgeted Pixar originals to break on Disney+.

During the pandemic's peak, when many cinemas were closed, Disney launched three Pixar films directly to Disney+ in the US, bypassing theaters. While the strategy boosted the subscription streaming service's subscriptions, it sent a message to viewers: It's OK to wait, said one veteran studio executive who worked at both Disney and Pixar, and worries this decision degraded the perception of Pixar movies, which cost as much as $200 million to make, as must-see theatrical events.

"In the long run, there’s been a bit of a mixed blessing because we’ve trained audiences that these films will be available for you on Disney+," Docter told Variety. "And it’s more expensive for a family of four to go to a theater when they know they can wait and it’ll come out on the platform."



‘Shoot Me up with a Big One’: A Timeline of the Last Days of Matthew Perry

 Actor Matthew Perry arrives at the 64th Primetime Emmy Awards in Los Angeles on Sept. 23, 2012. (Photo by Jordan Strauss/Invision/AP, File)
Actor Matthew Perry arrives at the 64th Primetime Emmy Awards in Los Angeles on Sept. 23, 2012. (Photo by Jordan Strauss/Invision/AP, File)
TT

‘Shoot Me up with a Big One’: A Timeline of the Last Days of Matthew Perry

 Actor Matthew Perry arrives at the 64th Primetime Emmy Awards in Los Angeles on Sept. 23, 2012. (Photo by Jordan Strauss/Invision/AP, File)
Actor Matthew Perry arrives at the 64th Primetime Emmy Awards in Los Angeles on Sept. 23, 2012. (Photo by Jordan Strauss/Invision/AP, File)

The arrest of five people in the overdose death of Matthew Perry has revealed key details about the final days of the “Friends” star, most of them spent in the throes of an addiction to the surgical anesthetic ketamine.

Perry would die at age 54 on Oct. 28 after telling his assistant to shoot him up “with a big one.” Drawn from unsealed federal court documents and a medical examiner’s investigation, here’s a chronological look at the end of Perry’s life.

The final month

September 30 — Perry and his live-in personal assistant, Kenneth Iwamasa, met at their home in the Pacific Palisades neighborhood of Los Angeles with Dr. Salvador Plasencia. Perry had been receiving ketamine treatments for depression — an increasingly common off-label use — from his regular doctor, but wasn’t able to get as much as he wanted. Plasencia texted a doctor friend in San Diego, Mark Chavez, who agreed to obtain ketamine for him.

“I wonder how much this moron will pay,” Plasencia texted Chavez. The two met up the same day in Costa Mesa, halfway between Los Angeles and San Diego and exchanged at least four vials of ketamine.

Plasencia returned to Perry’s house, where Iwamasa paid him $4,500 in cash for the vials. Plasencia gave Perry two injections of ketamine, and instructed Iwamasa on how to give the injections to the actor. Plasencia texted Chavez that the experience “felt like a bad movie.”

October 2 — Iwamasa texted Plasencia saying he wanted to buy not just injection sessions, but to be left with more vials of ketamine, referring to it in agreed-upon code as “dr pepper.” Plasencia appeared, gave Perry the injections, and left behind the vials of the anesthetic.

October 4 — Iwamasa injected Perry himself for the first time. He texted the doctor that he had found “the sweet spot” to put the needle into his boss, but that trying different spots on Perry had led to them running out, and they needed more. Plasencia texted Chavez asking if he could keep supplying the drug so they could become Perry’s “go-to.”

October 6 — Iwamasa told Plasencia they were running low, and needed more. Plasencia went to Perry’s house and sold him one or more vials.

October 8 — In a late night meetup at a Santa Monica shopping plaza, Plasencia sold Iwamasa four vials of ketamine for $6,000 in cash.

October 10 — Iwamasa drove Perry to a public parking lot in Long Beach, where they met up with the doctor. He sold them more ketamine, and gave an injection to Perry while the actor sat in a car. On the same day, Iwamasa sought even more of the drug from an additional source of ketamine, reaching out to Erik Fleming, an acquaintance of Perry.

October 11 — Fleming messaged Iwamasa that he can get ketamine from a woman he knows. “It’s unmarked but it’s amazing – he take one and try it and I have more if he likes,” Fleming wrote. The woman, Jasveen Sangha, was known to her customers as the “Ketamine Queen.” Fleming texted Iwamasa that she only deals “with high end and celebs. If it were not great stuff she’d lose her business.”

October 12 — Plasencia went to Perry’s house, where he was paid $21,000 in cash, some of it owed to him for previous ketamine buys. While there he injected Perry. The actor immediately froze up and his blood pressure spiked. The assistant said the doctor told him, “let’s not do that again.”

October 13 — Perry got a sample of Sangha’s ketamine and tried it. He and Iwamasa would ask for 25 vials of it, for which he would pay $5,500. Fleming dropped it off at Perry’s house a day later.

On or around Oct. 20 — Perry received his last legal ketamine treatment from his regular physician, according to what a woman close to him whose name was redacted in official documents told medical examiner’s investigators. The woman said his previous doctor had given him treatments every other day, but his new doctor said Perry was doing well, his depression was managed, and he no longer needed so many treatments. The woman would tell investigators that she had believed Perry had been sober for 19 months and there had been no relapse.

The final week

Around October 24 — Perry talked to the unidentified woman for the last time. She told investigators he had been in good spirits.

October 25 — Iwamasa asked Fleming for another 25 vials of ketamine. After picking up $6,000 from Perry, Fleming picked up the ketamine from Sangha, who told him her own source is known as “Master Chef.” Meanwhile, Iwamasa gave Perry at least six shots of ketamine.

October 26 — Iwamasa again gave Perry at least six shots of ketamine.

October 27 — The assistant again gave the actor at least six shots of ketamine. With the supply coming from Fleming and Sangha, Perry and Iwamasa had been out of touch with Plasencia for about two weeks. Plasencia would text Iwamasa saying he had more to offer: “I know you mentioned taking a break. I have been stocking up.”

The final day

About 8:30 a.m. — Acting at Perry’s direction, using syringes from Plasencia and ketamine from Sangha, Iwamasa gave Perry an injection.

About 11 a.m. — Perry played pickleball, according to what Iwamasa told medical examiner’s investigators later in the day, though many elements of that initial story changed in his later talks to prosecutors.

About 12:45 p.m. — Iwamasa gave Perry his second shot of the day, and the actor began watching a movie.

Shortly before 1:30 p.m. — Iwamasa gave Perry his third and final injection of the day while Perry sat at his backyard jacuzzi. “Shoot me up with a big one,” Iwamasa remembered Perry telling him. The assistant then left to run errands.

About 4 p.m. — Iwamasa returned home to find Perry face down in the jacuzzi. He jumped in, pulled Perry to the steps and called 911. Paramedics arrived minutes later and declared Perry dead. Coroner’s investigators would say ketamine was the primary cause of his death, with drowning a secondary cause.

The defendants now

Iwamasa has pleaded guilty to conspiracy to distribute Ketamine. Fleming has pleaded guilty to distributing ketamine resulting in death. Both are cooperating with prosecutors.

Chavez has agreed to plead guilty to conspiracy to distribute the drug. Plasencia and Sangha, the two main targets of the investigation, have pleaded not guilty to multiple felony counts.

Plasencia’s lawyer Stefan Sacks said Thursday that everything his client did was in Perry’s best medical interest. Sangha’s attorney declined comment.

Attorneys for the other three men did not respond to multiple messages seeking comment from The Associated Press.